Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Characteristics and outcomes of osteomyelitis in children with sickle cell disease: a retrospective review of a 10-year single-center experience
source: American Society of Pediatric Hematology/Oncology
year: 2017
authors: Julie Weisman, Deepika Darbari, Yaser Diab
summary/abstract:Background:
Patients with sickle cell disease (SCD) are at increased risk for Osteomyelitis (OM). Diagnosis of OM in this population is challenging and there is limited pediatric data on the characteristics and outcomes of OM in this population.
Objectives:
To report characteristics and outcomes of OM in children with SCD treated at our center over the last 10 years.
Results:
Thirty children with SCD (18 males, median age 12 years) were treated for OM at our institution during the study period. The genotype was SS in 27 patients, SC in 2, and SF in 1. Sites of involvement included lower extremity (11), upper extremity (10), pelvis (2), vertebrae (2), scapula (1), clavicle (1), hand (1), ribs (1) and mandible (1). Leukocytosis (>15,000/mm3) was observed in 13 patients (43%) at presentation. Baseline erythrocyte sedimentation rate was elevated (>20 mm/hour) in 29 patients (97%) but marked elevation (>100 mm/hour) was present in 3 patients (10%). Baseline C-reactive protein was elevated (>10 mg/L) in 13 patients (43%). Bacteremia was present in 6 patients (20%). Magnetic resonance imaging (MRI) findings were suggestive of OM in 18 patients (60%) and indeterminate in the remaining patients. The diagnosis of OM was confirmed in 3 patients (bone biopsy), probable in 6 patients (organism isolated from blood or abscess), and presumed in the remaining cases based on clinical, laboratory, and MRI findings. Non-typhoidal Salmonella was isolated from cultures in 9 (30%) patients [bone biopsy (3), abscess (3), and blood (6)] while no organism was found in the remaining 21 (70%) patients. All patients were treated with prolonged antibiotic therapy. Six patients required surgical drainage/debridement. Two patients developed chronic OM. There were no mortalities and complete resolution of OM was achieved in all patients.
Conclusion:
Despite improvements in the management of SCD over the past decade, OM continues to be a serious infection in children with SCD associated with significant morbidity. The majority of patients are treated for presumed diagnosis of OM without definitive confirmation. Non-typhoidal Salmonella was the only organism identified in our patient cohort.
Related Content
-
Spectra Optia Device Save Way to Treat Sickle Cell While Using Less Blood Cell Packs, Study FindsThe blood-separation device Spectra Opti...
-
David Williams, MDDr. Williams is the president of Dana-Fa...
-
Stigmatization of Sickle Cell Disease – Selina Olwenda-Chairperson Children Sickle Cell Foundationhttps://www.youtube.com/watch?time_conti...
-
Newborn Blood Spot Screening for Galactosemia, Tyrosiemia Type I, Homocystinuria, Sickle Cell Anemia, Sickle Cell/Be...Existing evidence reviews on newborn blo...
-
Sickle Cell Trait Knowledge and Health Literacy in Caregivers Who Receive In-Person Sickle Cell Trait EducationBackground: Despite universal screening...
-
Gene therapy targets sickle-cell diseaseElliott Vichinsky estimates that at leas...
-
Stress and Mental Health in SCD Interview Clipshttps://www.youtube.com/watch?v=LCcSTC-X...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.